8-K
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
May 12, 2009
Date of Report (Date of Earliest Event Reported)
Neurologix, Inc.
(Exact name of Registrant as Specified in its Charter)
         
Delaware   000-13347   06-1582875
(State or other Jurisdiction   (Commission File Number)   (I.R.S. Employer Identification No.)
of Incorporation or Organization)        
One Bridge Plaza, Fort Lee, New Jersey 07024
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (201) 592-6451
(Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

TABLE OF CONTENTS
 
Item 2.02. Results of Operations and Financial Condition
Item 9.01. Financial Statements and Exhibits
SIGNATURES
EX-99.1: PRESS RELEASE

 

 

Item 2.02. Results of Operations and Financial Condition.
On May 12, 2009, Neurologix, Inc. issued a press release announcing its financial results for the first quarter ended March 31, 2009. The entire text of the press release is attached as Exhibit 99.1 and is incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
     
99.1
  Neurologix, Inc. Press Release, dated May 12, 2009.

 

 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  NEUROLOGIX, INC.
 		  
Date: May 12, 2009  By:   /s/ Marc L. Panoff    
    Name:   Marc L. Panoff   
    Title:   Chief Financial Officer, Secretary and Treasurer